Author Details

Moiseenko, Fedor V.

Issue Section Title File
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data PDF
(Rus)
Vol 23, No 2 (2021) CLINICAL ONCOLOGY Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report PDF
(Rus)
Vol 23, No 3 (2021) CLINICAL ONCOLOGY Malignant neoplasm of the bronchi and lung: Russian clinical guidelines PDF
(Rus)
Vol 23, No 4 (2021) CLINICAL ONCOLOGY Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON PDF
(Rus)
Vol 24, No 3 (2022) CLINICAL ONCOLOGY Malignant neoplasm of the bronchi and lung: Russian clinical guidelines PDF
(Rus)
Vol 24, No 4 (2022) CLINICAL ONCOLOGY Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study PDF
(Rus)
Vol 25, No 3 (2023) CLINICAL ONCOLOGY Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study PDF
(Rus)
Vol 26, No 1 (2024) Articles Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies